Nose Clinical Trials

• Paclitaxel in Treating Patients With Recurrent or Refractory Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00003327 - Active, not recruiting
  Nose Cancer; Oral Cancer
  
• Cetuximab Plus Cisplatin in Treating Patients With Metastatic or Recurrent Cancer of the Head and Neck That Has Not Responded to Cisplatin Chemotherapy
  ClinicalTrials.gov Identifier: NCT00004865 - Active, not recruiting
  Nose Cancer; Oral Cancer; Throat Cancer
  
• Radiation Therapy, Combination Chemotherapy, and Amifostine in Treating Patients With Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00003582 - Active, not recruiting
  Nose Cancer; Oral Cancer; Throat Cancer; Quality of Life
  
• Cisplatin-Epinephrine Injectable Gel Plus Paclitaxel and Carboplatin in Treating Patients With Recurrent Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00022217 - Active, not recruiting
  Nose Cancer; Oral Cancer; Throat Cancer
  
• Surgery, Radiation Therapy, and Combination Chemotherapy in Treating Patients With Recurrent Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00003777 - Active, not recruiting
  Oral Cancer; Throat Cancer; Nose Cancer
  
• Cleaning of the Nose After Sinus Surgery: Necessary or Only Bothersome?
  ClinicalTrials.gov Identifier: NCT00184392 - Active, not recruiting
  Acute Recurrent Rhinosinusitis
  
• Mastoid Bone Autograft for Dorsal Nasal Augmentation
  ClinicalTrials.gov Identifier: NCT00545428 - Recruiting
  Nose Deformities, Acquired
  
• Study of Streptococcus Pneumoniae in Nose and Throats of Infants With Acute Otitis Media
  ClinicalTrials.gov Identifier: NCT00195611 - Active, not recruiting
  Otitis Media; Otitis Media With Effusion; Pneumococcal Infections
  
• ZD1839 in Treating Patients With Metastatic or Recurrent Cancer of the Head and Neck
  ClinicalTrials.gov Identifier: NCT00015964 - Completed
  Nose Cancer; Oral Cancer; Throat Cancer
  
• Fluorouracil, Hydroxyurea, Cetuximab and Twice-Daily Intensity Radiation Therapy for Advanced Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00462735 - Recruiting
  Head and Neck Cancer; Cancer of the Pharynx; Cancer of the Larynx; Nose Neoplasms; Paranasal Sinus Neoplasms; Cancer of the Oral Cavity
  
• Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00006248 - Completed
  Nose Cancers; Oral Cancer; Throat Cancer
  
• High-Dose Radiation Therapy Plus Chemotherapy in Treating Patients With Advanced Nose or Throat Cancer
  ClinicalTrials.gov Identifier: NCT00052429 - Active, not recruiting
  stage II lymphoepithelioma of the nasopharynx; stage II squamous cell carcinoma of the nasopharynx; stage III lymphoepithelioma of the nasopharynx; ...
  
• Administration of EBV-Specific Cytotoxic T-Lymphocytes to Patients with EBV-Positive Cancer of the Nose and Throat
  ClinicalTrials.gov Identifier: NCT00074594 - Completed
  Nasopharyngeal Cancer; Epstein-Barr Virus Infections